Kindler and his wife, Sharon Sullivan, who works in the performing arts, have listed a four-bedroom, four-bath condo on West ...

They are two of the biggest rivals in the world of pharma. But the CEO of drug giant Pfizer has sprung to Moderna's defense following the Trump administration's decision to cut its funding for ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

For more than a decade, this is usually the time period when companies tout the steps they’re taking to lower carbon ...

Results from the Phase III VERITAC-2 trial demonstrated that vepdegestrant reduced the risk of disease progression or death ...

Earlier research has suggested that regular exercise can improve survival rates for colorectal cancer patients, and a new ...

An colon cancer study highlighted the importance of the National Cancer Institute, while cancer doctors got a look at a bispecific antibody newly licensed by Pfizer.

A Connecticut doctor who is an expert in his field said it is “one of the silent diseases that does not get the respect it ...

Trastuzumab deruxtecan plus pertuzumab outperformed standard-of-care therapy as first-line treatment for HER2-positive ...

Pfizer (NYSE:PFE) and Arvinas (NASDAQ:ARVN) announced Saturday their plans to submit a new drug application with the Food and ...

Wolfspeed bankruptcy watch, North Carolina lands more data centers, Duke University’s funding crunch, and an AI companion ...

Brad Lerman "and I have been talking about what makes sense for him and for our legal team and Brad will be leaving Starbucks ...